Published

The effects of psilocybin microdosing on perception: a double-blind controlled study

No abstract is available for this record.

Open source BibTeX RIS

Bibliographic context

Journal: OSF Preprints (OSF Preprints)
Date: 2019-01-30
Source: OpenAlex
DOI: Unavailable
PubMed: Unavailable

Authors

Michiel van Elk George Fejer Josephine Marschall Pascal Lempe

Watch author

Topics and keywords

psilocybin Microdosing Other Psilocybin Double blind Perception Psychology Medicine Hallucinogen Placebo Neuroscience Psychiatry Alternative medicine Pathology Psychedelics and Drug Studies Sexuality Behavior and Technology Body Image and Dysmorphia Studies

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Microevidence for microdosing with psilocybin mushrooms: a double-blind placebo-controlled study of subjective effects, behavior, creativity, perception, cognition, and brain activityZenodo (CERN European Organization for Nuclear Research) · 2021-11-29 Evolving Guidelines for the Use of Touch During a Clinical Trial of Group Psilocybin-Assisted TherapyPsychedelic Medicine · 2024-05-07 Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trialEClinicalMedicine · 2024-09-22 Endocrinology-informed neuroimaging in eating disorders: GLP1, orexins, and psilocybinTrends in Molecular Medicine · 2023-12-18 Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trialEClinicalMedicine · 2022-12-27 Computational Analysis of Psilocybin Effects on Three-Choice Touchscreen Reversal Learning in Rats: A Pilot StudyPsychedelic Medicine · 2026-02-02 PSilocybin for psYCHological and existential distress in PALliative care (PSYCHED-PAL): A single arm unblinded clinical trialPalliative Medicine · 2026-01-29 Psychedelic Treatment with Psilocybin: Addressing Medical Malpractice Risk and Physicians’ ConcernsThe Journal of Law Medicine & Ethics · 2024-12-31